Neumann is director of the Center for the Evaluation of Value and Risk (CEVR) at Tufts Medical Center. Crummer is a research assistant at CEVR. Kaltenboeck is a principal and head of prescription drug ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Prolific Machines, a biotechnology company revolutionizing biologics manufacturing, announced today that it has been accepted into the U.S. Food and Drug ...
The US Food and Drug Administration (FDA) accepts a wide variety of applications into its Emerging Technologies Program (ETP), and is not just focused on continuous manufacturing, said Joel Welch, ...
FDA Finalizes Guidance on Emerging Manufacturing Tech Program The US Food and Drug Administration (FDA) on Thursday finalized its guidance detailing how drugmakers can participate in the agency's ...
Forbes contributors publish independent expert analyses and insights. I cover the intersection of science, workforce, and industrial policy Edward (EJ) Ishman, an instructor at Central New Mexico ...
N-Sorb leverages Aptar CSP Technologies’ proven 3-Phase Activ-Polymer™ platform technology to address the pressing issue of N-nitrosamine impurities in pharmaceuticals. These impurities, classified as ...
The Defense Department released its share of the fiscal year 2025 president’s budget request March 11. But what does it mean for emerging technologies? Overall, the department’s request for science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results